Ibutop (Ibuprofen)

Ibuprofen in Ibutop blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in the skin, which lowers the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. By reducing prostaglandin levels at the site of application, the gel provides targeted analgesic and anti‑inflammatory effects.

The specific dose and frequency of Ibutop are determined by the prescribing healthcare professional based on the severity of symptoms, the area to be treated, and patient factors. Patients should follow the prescriber’s instructions and the product label for appropriate application.

The safety of topical ibuprofen during pregnancy or lactation has not been definitively established. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks with their healthcare provider before using Ibutop.

To order Ibutop, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibutop delivers ibuprofen directly to the skin, providing localized pain relief with lower systemic absorption compared with oral ibuprofen. This can reduce the risk of gastrointestinal and renal side effects, but it may be less suitable for widespread or severe pain that requires systemic therapy.

Store Ibutop at room temperature, ideally below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat, and direct sunlight to maintain its stability and effectiveness.

Apply a thin layer of Ibutop to the affected skin area, gently massaging it in until fully absorbed. Use only on clean, dry, intact skin and avoid covering the area with occlusive dressings unless directed by a healthcare professional.

Serious risks, though rare, include severe allergic reactions such as angioedema, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and systemic NSAID toxicity (e.g., gastrointestinal ulceration or renal impairment) especially when large skin areas are treated.

Ibutop should not be used by individuals with a known hypersensitivity to ibuprofen or other NSAIDs, on broken or infected skin, or by patients who have experienced severe cutaneous adverse reactions to topical NSAIDs. Consultation with a healthcare professional is advised before use in these cases.